040 — Enmetazobactam for cUTI, Dupilumab for COPD, Melphalan Flufenamide Withdrawal, Teclistamab Biweekly Dosing, Linvoseltamab in RRMM
Here is information on the latest US FDA approvals, the week of February 19 – February 23, 2024 ChatGPT4 in medical writing and editing—visit learnAMAstyle.com com for medical writing assistance…